Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US Stock Insider Trading | Erasca disclosed two insider trading transactions on March 6
On March 6, 2026, Erasca (ERAS) disclosed two insider trading transactions. Executive Morris Shannon purchased 20,000 shares on March 4, 2026.
【Recent Insider Transactions】
【Company Information】
Erasca, Inc. was incorporated on July 2, 2018 in Delaware. The company is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for cancers driven by the RAS/MAPK pathway. The company was co-founded by leading pioneers in precision oncology and RAS-targeting, aiming to create new therapies and combination regimens, with the goal of comprehensively shutting down the RAS/MAPK pathway to treat cancer.